Dasatinib

Dasatinib is a multikinase inhibitor with potent activity against BCR–ABL kinase (IC50 <1 nM) and SFKs (IC50 of 0.2–1.1nM) that has been approved by the US Food and Drug Administration (FDA) for the treatment of patients with CML following failure or with intolerance to imatinib therapy. Small molecule inhibitor of both the SRC and BCR/ABL tyrosine kinases, with IC50's for the isolated kinases of 0.55 and 3.0 nM, respectively. Dasatinib also inhibits Lyn (IC50 = 8.5 nM) and Src (IC50 = 3.0 nM) kinase activities in vitro using 0.1 mg/mL poly (Glu4-Tyr) as the substrate. Dasatinib has greater potency than imatinib mesylate and has activity against the majority of kinase mutations in imatinib-resistant chronic myeloid leukemia.

Sku #Product NameProduct SizePriceQTY
1100145002 Dasatinib 500mg 500mg $53.00 USD
1100140013 Dasatinib 1g 1g $94.00 USD
1100140023 Dasatinib 2g 2g $158.00 USD
1100140053 Dasatinib 5g 5g $328.00 USD
1100140103 Dasatinib 10g 10g $545.00 USD
 

Add to Cart

Molecular Weight: 488.01 g/mol
Molecular Formula: C22H26CIN7O2S
CAS Number: 302962-49-8
Solubility in / Miscibility with water: very poorly soluble in water
Organic solvents: soluble in DMSO; very poorly soluble in ethanol
Purity:

99%

Storage: -20C

Material Safety Data Sheet

Date:Oct 22,2015

1. PRODUCT AND COMPANY IDENTIFICATION

1.1 Product identifier

Product name: Dasatinib

Catalog No:1100145002,1100140013,1100140023,1100140053,1100140103

1.2 Relevant identified uses of the substance or mixture and uses advised against

For research use only.

1.3 Details of the supplier of the safety data sheet

Company:Eton Bioscience Inc

TollFree:1-800-758-1630

Tel:1-800-758-1630

Fax:1-800-507-2912

1.4 Emergency telephone number

1-800-758-1630

2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture

Not a dangerous substance or mixture

2.2 GHS Label elements, including precautionary statements

Not a dangerous substance or mixture

2.3 Other hazards

None

3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances

Molecular Formula: C22H26CIN7O2S

Molecular Weight:488.01g/mol

CAS No:302962-49-8

4. FIRST AID MEASURES

4.1 Description of first aid measures

Eye contact

Check for and remove contact lenses and flush with copious amounts of water; assure adequate flushing by separating the eyelids with fingers; call a physician

Skin Contact

flush with copious amounts of water; remove contaminated clothing and shoes; call a physician

Inhalation

If inhaled, remove to fresh air; if breathing is difficult, give oxygen; if breathing stops, give artificial respiration

Ingestion

if swallowed, wash out mouth with copious amounts of water. DO NOT induce vomiting. Call a physician

4.2 Most important symptoms and effects, both acute and delayed

No information available

4.3 Indication of any immediate medical attention and special treatment needed.

No information available

5. FIRE FIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

water spray, carbon dioxide, dry chemical powder or foam

5.2 Special hazards arising from the substance or mixture

No information available

5.3 Advice for firefighters

Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.

6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions,protective equipment and emergency procedures

Use full personal protective equipment. Evacuate personnel to safe areas.

6.2 Environmental precautions

Prevent further leakage or spillage. Prevent product from entering drain.

6.3 Methods and material for containment and cleaning up

Absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); decontaminate surfaces and equipment by scrubbing with alcohol; dispose of contaminated material according to Section 13

7. HANDLING AND STORAGE

7.1 Precautions for safe handling

Avoid skin/eye contact. Use protective equipment as needed. Wash contaminated clothing before reuse.

7.2 Conditions for safe storage,including any incompatibilities

Keep container tightly closed in a cool,well-vented place. Store at -20˚C.

7.3 Specific end use(s)

No data available.

8. EXPOSURE CONTROLS/PERSONAL INFORMATION

8.1 Control Parameters

This product contains no hazardous materials with occupational exposure limits.

8.2 Exposure controls

Engineering controls

Provide shower and eye wash station

Personal protective equipment

Eye Protection

Wear safety goggles

Skin Protection

Wear protective clothing

Hand Protection

Wear protective gloves

Respiratory protection

Wear NIOSH/MSHA approved respirators

9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

Appearance

Solid

pH

No data available

Melting point

No data available

Freezing point

No data available

Boiling point

No data available

Density

No data available

Water solubility

Very poorly soluble

9.2 Other safety information

No data available.

10. STABILITY AND REACTIVITY

10.1Reactivity

No data available

10.2Chemical stability

Stable under recommended storage conditions.

10.3Possibility of hazardous reactions

No data available.

10.4Conditions to avoid

Protect from light and heat

10.5Incompatible materials

strong oxidizing agents

10.6Hazardous decomposition products

Thermal decomposition may produce toxic gases such as carbon monoxide, carbon dioxide, and nitrogen oxides

11. TOXICOLOGICAL INFORMATION

11.1Information on toxicological effects

Toxicological effects on this product have not been thoroughly studied.

12. ECOLOGICAL INFORMATION

12.1Toxicity

Avoid release into environment

12.2Persistence and degradability

No data available

12.3.Bioaccumlative potential

No data available

12.4Mobility in soil

No data available

12.5Results of PBT and vPvB assessment

No data available

12.6Other adverse effects

No data available

13. DISPOSAL INFORMATION

13.1Waste treatment methods

Dispose in accordance with local, state, and federal regulations.

14. TRANSPORT INFORMATION

DOT:
Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport
IATA:
Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport

IMDG:

Proper shipping name: none
Non-Hazardous for transport: this substance is considered to be non-hazardous for transport

15. REGULATORY INFORMATION

EU Risk and Safety phrases:

R22: Harmful if swallowed

S22: Do not breathe dust

S24/25: Avoid contact with skin and eyes

S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice

S28:after contact with skin, wash immediately with plenty of water

S36/37/39:Wear suitable protective clothing,gloves and eye/face protection

16. OTHER INFORMATION

The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information. Eton Bioscience Inc. shall not be held liable for any damages or other consequences resulting from handling or from contact with the above product.

Clint Mitchell,Hossein A Hamed, Nichola Cruickshanks, Yong Tang, M. Danielle Bareford,Nisan Hubbard,Gary Tye,Adly Yacoub,Yun Dai,Steven Grant,and Paul Dent. Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death. Cancer Biol Ther. Aug 1, 2011; 12(3): 215-228.
C Fialin, C Larrue, F Vergez, J E Sarry, S Bertoli, V Mansat-De Mas, C Demur, E Delabesse, B Payrastre, S Manenti, S Roche and C Récher. The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors. Leukemia (20August2012) | doi:10.1038/leu.2012.240
J Hu, K A Muller, F B Furnari, W K Cavenee, S R VandenBerg and S L Gonias. Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. Oncogene 34, 4078-4088 (30 July 2015) | doi:10.1038/onc.2014.336

Copyright © 2003-2018

All Rights Reserved

Eton Bioscience, Inc.
5820 Oberlin Drive, Suite 108
San Diego, CA 92121
DNA Sequencing
Specialty DNA Sequencing
Direct Sequencing
Genomic Services
Fragment Analysis
Mammilian Cell Expression
Peptide Synthesis
Antibody Services
DNA Prep Service
Facebook LinkedIn Google Plus Twitter